secwatch.observer — SEC 8-K summary
======================================

Issuer:     Perspective Therapeutics, Inc. (CATX)
CIK:        0000728387
Form:       8-K
Filed at:   2026-02-03T23:59:59+00:00
Accession:  0001193125-26-035508
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Perspective Therapeutics prices $175M offering of common stock and pre-funded warrants at $3.79/share
--------------------------------------------------------------------------------

- Gross proceeds ~$175M from 39,576,088 shares at $3.79/share and 6,598,046 pre-funded warrants at $3.789.
- Offering closed Feb 3, 2026; net proceeds to fund clinical development, manufacturing, and general corp purposes.
- Underwriters include Piper Sandler, UBS, Oppenheimer, Truist, and LifeSci Capital.
- Participation from Commodore Capital, TCGX, Spruce Street Capital, Surveyor Capital (Citadel), and others.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/728387/000119312526035508/0001193125-26-035508-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/728387/000119312526035508/catx-20260202.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-035508

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer